Serbian Health Fund Criticized for Slow Approval of Innovative Medicines

Dr. Dragan Delić, a Serbian MP and health committee president, criticized the RFZO for approving only 10 innovative medicines since 2023, questioning the slow pace of access to new treatments.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

n1-serbiaCroatian4h ago

Dr Delić: Zašto od 2023. godine RFZO nije odobrio nijedan inovativni lek, a sada svega 10?

Predsednik Odbora za zdravlje Srbija centra (SRCE) i poslanik u Skupštini dr Dragan Delić, redovni profesor Medicinskog fakulteta u penziji, pozdravio

Read full article →

PERSPECTA

PERSPECTA

Serbian Health Fund Criticized for Slow Approval of Innovative Medicines

Sources

Dr Delić: Zašto od 2023. godine RFZO nije odobrio nijedan inovativni lek, a sada svega 10?

Related Stories

Four arrested for selling P102 million in fake anti-cancer medicines in Makati

Vigilance Urged After Death of Two Children in Abandoned Car

Calapan City heat index hits dangerous 44°C

Muntinlupa City Representative Urges MWSS to Address Water Supply Interruptions

PERSPECTA